Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 1, 2000, Pages 33-40

  Jenkinson, Crispin ^a   Fitzpatrick, Ray ^a   Brennan, Cathy ^a   Swash, Michael ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

ALS MND; ALSAQ 40; Quality of life; Self reported health status

Indexed keywords

EID: 80051763707     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/146608299300080022     Document Type: Article

References (14)

1. Hobart J, Lamping D, Thomson A. Evaluating neurological outcome measures. J Neurol Neurosurg Psychiatry 1996; 60: 127-130.
2. Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Development and validation of the ALSAQ-40. J Neurol 1999 (in press).
3. Ware J, Sherbourne C. The MOS 36-item short-form health survey 1. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
4. The ALS CNTF Treatment Study Group (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Arch Neurol 1996; 53: 141-147.
5. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V for the Amyotrophic Lateral Sclerosis/Riluzole Study Group. II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-1431. (Pubitemid 26161204)
6. Swash M. Health outcome and quality of life measurements in amyotrophic lateral sclerosis. J Neurol 1997; 244 (suppl 2): S25-S29.
7. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. Transition questions to assess outcomes in rheumatoid arthritis. Br J Rheumatol 1993; 32: 807-811. (Pubitemid 23267599)
8. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
9. Jenkinson C, McGee H. Health Status Measurement: A Brief but Critical Introduction. Oxford: Radcliffe Medical Press, 1998.
10. Ware J. Measurements for a new era of health assessment. In: Stewart A, Ware J, eds. Measuring Functioning and Well Being. Durham, NC: Duke University Press, 1992.
11. Robinson I, Hunter M. Motor Neurone Disease. London: Routledge, 1998.
12. Shields RK, Ruhland JL, Ross MA, Saehler MM, Smith KB, Heffner M. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam. Arch Phys Med Rehabil 1998; 79: 855-856
13. Jenkinson C, Swash M. Health outcome measures. In: Brown R, Meininger V, Swash M, eds. Amyotrophic Lateral Sclerosis. London: Martin Dunitz, 1999.
14. Juniper E, Guyatt G, Willan A, Grifith L. Determining a minimal important difference in a disease speciic quality of life questionnaire. J Clin Epidemiol 1994; 47; 81-87. (Pubitemid 24034293)